[HTML][HTML] Senolytic targeting of Bcl-2 anti-apoptotic family increases cell death in irradiated sarcoma cells

J Lafontaine, GB Cardin, N Malaquin, JS Boisvert… - Cancers, 2021 - mdpi.com
Simple Summary Limited volumetric change after pre-operative radiotherapy (RT) suggests
that sarcomas generally do not undergo cell death. Senolytic drugs represent a highly …

Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells

J Lafontaine, GB Cardin, N Malaquin… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Radiotherapy (RT) is a key component of cancer treatment. Most of the time, radiation is
given after surgery but for soft-tissue sarcomas (STS), pre-surgical radiation is commonly …

[PDF][PDF] Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells

J Lafontaine, GB Cardin, N Malaquin… - Radiother …, 2005 - researchgate.net
Radiotherapy (RT) is a key component of cancer treatment. Most of the time, radiation is
given after surgery but for soft-tissue sarcomas (STS), pre-surgical radiation is commonly …

Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells

J Lafontaine, GB Cardin, N Malaquin, JS Boisvert… - tspace.library.utoronto.ca
Radiotherapy (RT) is a key component of cancer treatment. Most of the time, radiation is
given after surgery but for soft-tissue sarcomas (STS), pre-surgical radiation is commonly …

[PDF][PDF] Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells

J Lafontaine, GB Cardin, N Malaquin… - Radiother …, 2005 - pdfs.semanticscholar.org
Radiotherapy (RT) is a key component of cancer treatment. Most of the time, radiation is
given after surgery but for soft-tissue sarcomas (STS), pre-surgical radiation is commonly …

Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells

J Lafontaine, GB Cardin, N Malaquin… - Radiother …, 2005 - search.proquest.com
Radiotherapy (RT) is a key component of cancer treatment. Most of the time, radiation is
given after surgery but for soft-tissue sarcomas (STS), pre-surgical radiation is commonly …

[HTML][HTML] Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells

J Lafontaine, GB Cardin, N Malaquin, JS Boisvert… - Cancers, 2021 - ncbi.nlm.nih.gov
Radiotherapy (RT) is a key component of cancer treatment. Most of the time, radiation is
given after surgery but for soft-tissue sarcomas (STS), pre-surgical radiation is commonly …

Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells.

J Lafontaine, GB Cardin, N Malaquin, JS Boisvert… - Cancers, 2021 - europepmc.org
Radiotherapy (RT) is a key component of cancer treatment. Most of the time, radiation is
given after surgery but for soft-tissue sarcomas (STS), pre-surgical radiation is commonly …

Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells.

J Lafontaine, GB Cardin, N Malaquin, JS Boisvert… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Limited volumetric change after pre-operative radiotherapy (RT)
suggests that sarcomas generally do not undergo cell death. Senolytic drugs represent a …